Zobrazeno 1 - 10
of 643
pro vyhledávání: '"Neutralising antibodies"'
Autor:
D. S. Leontyev, F. A. Urusov, D. V. Glazkova, B. V. Belugin, O. V. Orlova, R. R. Mintaev, G. M. Tsyganova, E. V. Bogoslovskaya, G. A. Shipulin
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 312-321 (2024)
INTRODUCTION. Despite existing treatment methods, complete eradication of human immunodeficiency virus (HIV) infection remains an unattainable goal due to the high variability of HIV type 1 (HIV-1). HIV infection necessitates life-long administration
Externí odkaz:
https://doaj.org/article/b076f82274424b8192a6f8cb79b849bc
Autor:
Mikael Kajova, Tamim Khawaja, Iris Levonen, Jukka-Pekka Pietilä, Jenni Virtanen, Sari H. Pakkanen, Hanna Välimaa, Arttu Nousiainen, Jussi Hepojoki, Tarja Sironen, Antti Vierikko, Jarkko Ihalainen, Olli Vapalahti, Anu Kantele
Publikováno v:
New Microbes and New Infections, Vol 62, Iss , Pp 101525- (2024)
Background: Early in the COVID-19 pandemic, convalescent plasma (CP) emerged as a potentially effective treatment neutralising SARS-CoV-2. Early CP therapy with high neutralising antibody (NAb) titre may benefit COVID-19 outpatients and, in sufficien
Externí odkaz:
https://doaj.org/article/4c832eee5dcf4fef9977fa7ccb6c94b1
Autor:
Carla Nel, John Frater
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Although HIV infection can be managed with antiretroviral drugs, there is no cure and therapy has to be taken for life. Recent successes in animal models with HIV-specific broadly neutralising antibodies (bNAbs) have led to long-term virological remi
Externí odkaz:
https://doaj.org/article/464785008ae74d1c8f02428291f5a1fe
Autor:
Claudia Maria Trombetta, Giulia Accardi, Anna Aiello, Anna Calabrò, Calogero Caruso, Mattia Emanuela Ligotti, Serena Marchi, Emanuele Montomoli, Martin Mayora Neto, Nigel Temperton, Giuseppina Candore
Publikováno v:
Immunity & Ageing, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Although it is well known that the older people have been the most susceptible to COVID-19, there are conflicting data on the susceptibility of centenarians. Two epidemiological study have shown that older centenarians (> 101 year
Externí odkaz:
https://doaj.org/article/449bf73678ce427e8fd5e4d94e7258eb
Autor:
Cheng Siang Tan, Madinah Adrus, Sultana Parvin Habeebur Rahman, Haziq Izzuddin Muhamad Azman, Riz Anasthasia Alta Abang
Publikováno v:
BMC Veterinary Research, Vol 20, Iss 1, Pp 1-7 (2024)
Abstract Background SARS-CoV-2 is believed to have originated from a spillover event, where the virus jumped from bats to humans, leading to an epidemic that quickly escalated into a pandemic by early 2020. Despite the implementation of various publi
Externí odkaz:
https://doaj.org/article/7e37c0cd314344d691ebd9e7f98485de
Autor:
Kegomoditswe Malebo, Jeremy Woodward, Phindile Ximba, Qiniso Mkhize, Sanele Cingo, Thandeka Moyo-Gwete, Penny L. Moore, Anna-Lise Williamson, Rosamund Chapman
Publikováno v:
Vaccines, Vol 12, Iss 9, p 1063 (2024)
Despite treatment and other interventions, an effective prophylactic HIV vaccine is still an essential goal in the control of HIV. Inducing robust and long-lasting antibody responses is one of the main targets of an HIV vaccine. The delivery of HIV e
Externí odkaz:
https://doaj.org/article/f66ab97b60f14884ae590f25fd767ae5
Autor:
Dana Kälin, Angela Becsek, Helen Stürmer, Claudia Bachofen, Denise Siegrist, Hulda R. Jonsdottir, Angelika Schoster
Publikováno v:
Vaccines, Vol 12, Iss 9, p 1074 (2024)
(1) Background: Horses infected by a tick-borne encephalitis virus (TBEV) can develop clinically apparent infections. In humans, vaccination is the most effective preventive measure, while a vaccine is not available for horses. The objective of this
Externí odkaz:
https://doaj.org/article/7aae38047d67479f9246cf08413ca1cb
Autor:
Panagiota Zacharopoulou, Ming Lee, Thiago Oliveira, John Thornhill, Nicola Robinson, Helen Brown, Sabine Kinloch, Philip Goulder, Julie Fox, Sarah Fidler, M. Azim Ansari, John Frater
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Broadly neutralising antibodies (bNAbs) targeting HIV show promise for both prevention of infection and treatment. Among these, 10-1074 has shown potential in neutralising a wide range of HIV strains. However, resistant viruses may limit the clinical
Externí odkaz:
https://doaj.org/article/64915d7639e0415280ddaf032c59335a
Autor:
Karla Rottmayer, Mandy Schwarze, Christian Jassoy, Ralf Hoffmann, Henry Loeffler-Wirth, Claudia Lehmann
Publikováno v:
Biology, Vol 13, Iss 4, p 273 (2024)
Serological assays for SARS-CoV-2 play a pivotal role in the definition of whether patients are infected, the understanding of viral epidemiology, the screening of convalescent sera for therapeutic and prophylactic purposes, and in obtaining a better
Externí odkaz:
https://doaj.org/article/2d0fe87bc38642c1b482ae692b2d01a9
Autor:
D.A.T. Hanssen, D.M.E. Pagen, J. Penders, S. Brinkhues, N.H.T.M. Dukers-Muijrers, C.J.P.A. Hoebe, P.H.M. Savelkoul, I.H.M. van Loo
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 4, Pp 100164- (2023)
Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding domain (RBD) of the spike protein, protect against re-infection with SARS-CoV-2. Quantitative antibody response data provide insight into population
Externí odkaz:
https://doaj.org/article/e0d6ff6c27ee459e822160b867800d9d